The company's squashed the consensus estimate for third-quarter profitability, and impressed investors and analysts alike.Specialty materials producer ATI's (ATI 1.77%) stock has had quite a run lately. Its share price was rising by more than 13% week to date as of early Friday morning, according to data compiled by S&P Global Market Intelligence. Much of this was due to a beat-and-raise third quarter posted by the industrial company, aided by a pair of analyst price target increases. Skyrocketing aerospace ...

Truist Financial raises TE Connectivity Plc (NYSE: TEL) price target to $255 from $200, indicating a 4.27% potential upside.TEL reports quarterly adjusted earnings of $2.44 per share, beating estimates and marking a 25% year-over-year increase.Company projects first-quarter adjusted earnings per share of $2.53 and sales of $4.50 billion, surpassing consensus estimates.TE Connectivity Plc (NYSE: TEL), a leading global technology company specializing in connectivity and sensor solutions, competes with major i ...

Daniel Markowitz from Evercore ISI sets a new price target for NYSE:WST at $390, indicating a 26.1% potential increase.WST reports a strong third-quarter performance with adjusted EPS of $1.96, beating estimates by 17.4%.The company raises its full-year EPS outlook to $7.06 to $7.11, driven by strong demand and favorable foreign exchange conditions.West Pharmaceutical Services, Inc. (NYSE:WST) is a leading provider of innovative solutions for injectable drug administration. The company specializes in the de ...

行业趋势 - 多家美国大型公司上调2025年业绩指引 显示对持续增长势头的信心 尽管市场仍保持谨慎 [1] - 华尔街分析师纷纷上调目标价 反映对第二季度强劲业绩的积极回应 [1] Netflix (NFLX) - 将2025年收入指引中值从440亿美元上调至450亿美元 主要受外汇有利变动推动 [2][3] - 财报发布后股价下跌5% 因市场认为外汇因素不可持续 [3] - 分析师平均目标价达1477美元 隐含22%上涨空间 显著高于市场共识目标价1275美元 [4] Levi Strauss & Co (LEVI) - 将2025年收入预期从下降1%-2%调整为增长1%-2% 并上调调整后每股收益指引中值0.05美元至1.275美元 [5][6] - 分析师普遍上调目标价 其中瑞银集团目标价上调8美元 市场共识目标价23.45美元隐含12%上涨空间 [7] JPMorgan Chase & Co (JPM) - 第二季度业绩超预期 将2025年净利息收入指引上调10亿美元至955亿美元 该收入通常占公司总收入一半 [9][10] - 财报发布后分析师最新平均目标价325美元 隐含11%上涨空间 高于市场共识目标价289美元 [10] Johnson & Johnson (JNJ) - 将2025年收入预期上调20亿美元至932-936亿美元区间 调整后每股收益预期中值从10.60美元上调至10.85美元 [12][13] - 7月17日分析师上调目标价后平均目标价178美元 隐含9%上涨空间 高于市场共识目标价173美元 [14]